News & views in ... Immunotherapy.
D000818:Animals; D019138:Antibodies, Blocking / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D002986:Clinical Trials as Topic; D005260:Female; D000068876:Fingolimod Hydrochloride; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D006801:Humans; D020714:Maximum Tolerated Dose; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors; D053586:Virus Internalization / Q000187:drug effects
D019138:Antibodies, Blocking; D000970:Antineoplastic Agents; D015699:HIV Envelope Protein gp120; D011409:Propylene Glycols; D013940:Thymidylate Synthase; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine